1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Pharmaceutical Quality Management Software Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Pharmaceutical Quality Management Software Market, by Solution / Module Type
8.1.1. Document Management
8.1.1.1. Market Revenue and Forecast
8.1.2. Audit Management
8.1.2.1. Market Revenue and Forecast
8.1.3. CAPA (Corrective & Preventive Action) Management
8.1.3.1. Market Revenue and Forecast
8.1.4. Change Management
8.1.4.1. Market Revenue and Forecast
8.1.5. Supplier Quality Management
8.1.5.1. Market Revenue and Forecast 8.1.5. Lipid
8.1.6.1. Market Revenue and Forecast
8.1.6. Non-Conformance / Deviation Management
8.1.7.1. Market Revenue and Forecast
8.1.7. Training Management
8.1.8.1. Market Revenue and Forecast
8.1.8. Risk & Compliance Management
8.1.9.1. Market Revenue and Forecast
8.1.9. Inspection Management
8.1.1. Market Revenue and Forecast
8.1.10.1.Other Quality Modules
8.1.11. Market Revenue and Forecast
8.1.12. Lipid
8.1.5.12.1. Market Revenue and Forecast
9.1. Pharmaceutical Quality Management Software Market, by Deployment Mode
9.1.1. On-Premises Deployment
9.1.1.1. Market Revenue and Forecast
9.1.2. Cloud / Web-Based Deployment
9.1.2.1. Market Revenue and Forecast
9.1.3. Hybrid Deployment
9.1.3.1. Market Revenue and Forecast
10.1. Pharmaceutical Quality Management Software Market, by Enterprise Size
10.1.1. Large Enterprises
10.1.1.1. Market Revenue and Forecast
10.1.2. Medium Enterprises
10.1.2.1. Market Revenue and Forecast
10.1.3. Small & Emerging Pharma / Biotech
10.1.3.1. Market Revenue and Forecast
11.1. Pharmaceutical Quality Management Software Market, by End-User / Application Sector
11.1.1. Pharmaceutical & Biotechnology Manufacturers
11.1.1.1. Market Revenue and Forecast
11.1.2. Contract Development & Manufacturing Organizations (CDMOs) / CMOs
11.1.2.1. Market Revenue and Forecast
11.1.3. Research & Development (R&D) Organizations
11.1.3.1. Market Revenue and Forecast
11.1.4. Generic Drug Manufacturers
11.1.4.1. Market Revenue and Forecast
11.1.5. Regulatory / Compliance Authorities
11.1.5.1. Market Revenue and Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Solution / Module Type
12.1.2. Market Revenue and Forecast, by Deployment Mode
12.1.3. Market Revenue and Forecast, by Enterprise Size
12.1.4. Market Revenue and Forecast, by End-User / Application Sector
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Solution / Module Type
12.1.5.2. Market Revenue and Forecast, by Deployment Mode
12.1.5.3. Market Revenue and Forecast, by Enterprise Size
12.1.5.4. Market Revenue and Forecast, by End-User / Application Sector
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Solution / Module Type
12.1.6.2. Market Revenue and Forecast, by Deployment Mode
12.1.6.3. Market Revenue and Forecast, by Enterprise Size
12.1.6.4. Market Revenue and Forecast, by End-User / Application Sector
12.2. Europe
12.2.1. Market Revenue and Forecast, by Solution / Module Type
12.2.2. Market Revenue and Forecast, by Deployment Mode
12.2.3. Market Revenue and Forecast, by Enterprise Size
12.2.4. Market Revenue and Forecast, by End-User / Application Sector
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Solution / Module Type
12.2.5.2. Market Revenue and Forecast, by Deployment Mode
12.2.5.3. Market Revenue and Forecast, by Enterprise Size
12.2.5.4. Market Revenue and Forecast, by End-User / Application Sector
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Solution / Module Type
12.2.6.2. Market Revenue and Forecast, by Deployment Mode
12.2.6.3. Market Revenue and Forecast, by Enterprise Size
12.2.6.4. Market Revenue and Forecast, by End-User / Application Sector
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Solution / Module Type
12.2.7.2. Market Revenue and Forecast, by Deployment Mode
12.2.7.3. Market Revenue and Forecast, by Enterprise Size
12.2.7.4. Market Revenue and Forecast, by End-User / Application Sector
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Solution / Module Type
12.2.8.2. Market Revenue and Forecast, by Deployment Mode
12.2.8.3. Market Revenue and Forecast, by Enterprise Size
12.2.8.4. Market Revenue and Forecast, by End-User / Application Sector
12.3. APAC
12.3.1. Market Revenue and Forecast, by Solution / Module Type
12.3.2. Market Revenue and Forecast, by Deployment Mode
12.3.3. Market Revenue and Forecast, by Enterprise Size
12.3.4. Market Revenue and Forecast, by End-User / Application Sector
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Solution / Module Type
12.3.5.2. Market Revenue and Forecast, by Deployment Mode
12.3.5.3. Market Revenue and Forecast, by Enterprise Size
12.3.5.4. Market Revenue and Forecast, by End-User / Application Sector
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Solution / Module Type
12.3.6.2. Market Revenue and Forecast, by Deployment Mode
12.3.6.3. Market Revenue and Forecast, by Enterprise Size
12.3.6.4. Market Revenue and Forecast, by End-User / Application Sector
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Solution / Module Type
12.3.7.2. Market Revenue and Forecast, by Deployment Mode
12.3.7.3. Market Revenue and Forecast, by Enterprise Size
12.3.7.4. Market Revenue and Forecast, by End-User / Application Sector
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Solution / Module Type
12.3.8.2. Market Revenue and Forecast, by Deployment Mode
12.3.8.3. Market Revenue and Forecast, by Enterprise Size
12.3.8.4. Market Revenue and Forecast, by End-User / Application Sector
12.4. MEA
12.4.1. Market Revenue and Forecast, by Solution / Module Type
12.4.2. Market Revenue and Forecast, by Deployment Mode
12.4.3. Market Revenue and Forecast, by Enterprise Size
12.4.4. Market Revenue and Forecast, by End-User / Application Sector
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Solution / Module Type
12.4.5.2. Market Revenue and Forecast, by Deployment Mode
12.4.5.3. Market Revenue and Forecast, by Enterprise Size
12.4.5.4. Market Revenue and Forecast, by End-User / Application Sector
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Solution / Module Type
12.4.6.2. Market Revenue and Forecast, by Deployment Mode
12.4.6.3. Market Revenue and Forecast, by Enterprise Size
12.4.6.4. Market Revenue and Forecast, by End-User / Application Sector
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Solution / Module Type
12.4.7.2. Market Revenue and Forecast, by Deployment Mode
12.4.7.3. Market Revenue and Forecast, by Enterprise Size
12.4.7.4. Market Revenue and Forecast, by End-User / Application Sector
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Solution / Module Type
12.4.8.2. Market Revenue and Forecast, by Deployment Mode
12.4.8.3. Market Revenue and Forecast, by Enterprise Size
12.4.8.4. Market Revenue and Forecast, by End-User / Application Sector
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Solution / Module Type
12.5.2. Market Revenue and Forecast, by Deployment Mode
12.5.3. Market Revenue and Forecast, by Enterprise Size
12.5.4. Market Revenue and Forecast, by End-User / Application Sector
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Solution / Module Type
12.5.5.2. Market Revenue and Forecast, by Deployment Mode
12.5.5.3. Market Revenue and Forecast, by Enterprise Size
12.5.5.4. Market Revenue and Forecast, by End-User / Application Sector
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Solution / Module Type
12.5.6.2. Market Revenue and Forecast, by Deployment Mode
12.5.6.3. Market Revenue and Forecast, by Enterprise Size
12.5.6.4. Market Revenue and Forecast, by End-User / Application Sector
13.1. Veeva Systems
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. IQVIA
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Honeywell International Inc
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. MasterControl Solutions, Inc
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. ETQ
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Qualio
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. MasterControl
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client